National Impact Dashboard
Visualizing the scale, growth, and community impact of the 340B Drug Pricing Program using the latest 2024 data. These numbers represent real hospitals serving real communities—and the patients who depend on them.
Click on a state to filter the dashboard data
Total Purchases
Total 340B Purchases
$81.4 Billion
This is the total dollar value of discounted medications purchased by qualifying hospitals and clinics in 2024. These savings allow facilities to stretch limited budgets and provide more care to underserved patients.
Uncompensated Care
$48.9 Billion
This represents free or reduced-cost care provided to patients who cannot afford to pay. 340B hospitals provide this care regardless of a patient's ability to pay—it's care that would otherwise go unprovided.
Patient Lives Touched
20 Million+
Every year, 340B facilities serve millions of patients—from cancer treatments to diabetes management to prenatal care. Each number represents a person who received care they might not have been able to afford otherwise.
Program Status
Active Growth
The program continues to expand as more eligible hospitals and clinics recognize the value of 340B savings in serving vulnerable populations and maintaining financial sustainability.
This chart shows how the program has grown over time. Each billion dollars represents thousands of patients receiving medications they need—from insulin for diabetes to chemotherapy for cancer—at prices their hospitals can afford.
340B isn't just about cheaper drugs—it's about what hospitals do with those savings. This shows where the money goes: free clinics, mobile health units, patient assistance programs, and services that would otherwise be cut.
- 0
- 1
- 2
- 3
"Uncompensated care" means treating patients who can't pay—and not sending them a bill. This includes emergency room visits, surgeries, chronic disease management, and preventive care. Without 340B savings, many hospitals couldn't afford to provide this level of charity care.
This chart shows why 340B matters: DSH hospitals make up only a fraction of all hospitals, but they shoulder a disproportionate share of uncompensated care. They serve the poorest, sickest patients—and 340B helps them stay financially viable while doing it.
- Share of Uncompensated Care
- Share of Total Hospitals
💊 For Patients
A single cancer patient's treatment can cost $150,000+ per year. With 340B discounts (often 20-50% off), a hospital can afford to treat 2-3 patients for the cost of one. That's the difference between "we can help you" and "we can't afford to."
🏥 For Hospitals
A rural hospital saving $2 million annually through 340B can keep its emergency room open 24/7, hire two more nurses, or launch a diabetes prevention program. Without those savings, services get cut—or the hospital closes.
🏘️ For Communities
340B-funded mobile clinics bring care to homeless populations, migrant farmworkers, and underserved neighborhoods. Free HIV testing, prenatal care, and chronic disease management—services that prevent expensive ER visits and save lives.
📊 The Bottom Line
Every $1 billion in 340B purchases translates to roughly $200-300 million in savings that get reinvested into patient care. Multiply that across $70+ billion annually, and you're looking at tens of billions in community health services that wouldn't exist otherwise.
Data Sources & Methodology
Data presented in this dashboard is aggregated from publicly available reports by the Health Resources and Services Administration (HRSA), IQVIA Institute for Human Data Science (2024 Report), and the American Hospital Association (AHA). "Uncompensated Care" figures represent the total cost of charity care and bad debt provided by 340B covered entities. Patient impact metrics are estimated based on annual reporting from covered entities. All figures are verified against multiple independent sources to ensure accuracy.